["糖尿病的到来"助力决策 - - 一项定性评估研究的结果]
Nicole Lindner1, Marie-Christine Hoffman1, Nobert-Donner Banzhoff1
1Institut für Allgemeinmedizin, Universität Marburg, Marburg, Deutschland.
概括
一般医生发现"arriba糖尿病",一种用于2型糖尿病治疗强度的工具,是实用和可理解的. 决策辅助通过提供适当的治疗建议来支持共享决策 (SDM).
科学领域:
- 内分泌学 在内分泌学.
- 医疗信息学 医疗信息学
- 一般的做法一般的做法
背景情况:
- 对2型糖尿病 (T2DM) 建议以患者为中心的治疗和共享决策 (SDM),但未得到充分利用.
- "arriba Diabetes"是一个旨在促进SDM关于T2DM治疗强度的决策辅助工具.
- 该工具使用线性模型,结合患者的年龄,并发症和治疗和避免并发症的偏好.
研究的目的:
- 为了探索全科医生 (GPs) 对"到来糖尿病"工具的看法.
- 评估该工具建议的治疗强度的适当性,可理解性和完整性.
- 评估"到达糖尿病"在支持T2DM的SDM中的实际实用性.
主要方法:
- 一项涉及全科医生 (GPs) 的定性采访研究.
- 在全科医生使用"到来糖尿病"工具之前和之后进行了采访.
- 按照布劳恩和克拉克的方法论进行主题分析,用于分析采访数据.
主要成果:
- 整体医生普遍认为"arriba Diabetes"推的治疗强度是适当的.
- 该工具被认为是可以理解和教育的,有助于缓和冲突的讨论.
- 输入参数被认为是有意义的,尽管评估并发症和治疗努力带来了挑战.
结论:
- "arriba糖尿病"显示了作为一种实际工具来增强T2DM治疗强度的SDM的潜力.
- 决策辅助可以支持全科医生在与患者讨论治疗强度时提供支持.
- 进一步整合这些工具可能会改善T2DM管理中的以患者为中心的护理.
相关概念视频
Diabetes: Management and Pharmacotherapy
856
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
856
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
395
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
395
SBAR II: Application of SBAR
5.6K
SBAR is an effective communication tool used by healthcare professionals to communicate patient information accurately. SBAR stands for Situation, Background, Assessment, and Recommendation. For a better understanding, an example is given below.
SBAR Report from a Nurse to a Health Care Provider
S: "Hello, Dr. Smith. This is Jane, RN, from the Med Surg unit. I am calling to tell you about Ms. White in Room 210, who is experiencing increased pain and redness at her incision site. Her recent...
SBAR Report from a Nurse to a Health Care Provider
S: "Hello, Dr. Smith. This is Jane, RN, from the Med Surg unit. I am calling to tell you about Ms. White in Room 210, who is experiencing increased pain and redness at her incision site. Her recent...
5.6K
Nursing Evaluation
4.1K
The evaluation stage signals the end of the nursing process. The nurse gathers evaluative data to assess whether or not the patient has attained the expected results. Whereas the nurse collects data in the nursing assessment to identify the patient's health concerns, the evaluation stage data determines if the indicated health issues are resolved. Evaluative data collection includes two sections: the data acquired to evaluate patient outcomes and the time criteria for data collection.
4.1K
Diabetes Mellitus: Overview and Type I Subtype
4.8K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.8K
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
343
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
343


